Sudarshan Pharma Industries Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003813,
    "name": "Sudarshan Pharma",
    "stock_name": "Sudarshan Pharma",
    "full_name": "Sudarshan Pharma Industries Ltd",
    "name_url": "stocks-analysis/sudarshan-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "25.00",
    "chg": -0.93,
    "chgp": "-3.59%",
    "dir": -1,
    "prev_price": "25.93",
    "mcapval": "624.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543828,
    "symbol": "",
    "ind_name": "Specialty Chemicals",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE00TV01023",
    "curr_date": "Mar 05",
    "curr_time": "",
    "bse_nse_vol": 268000,
    "exc_status": "Active",
    "traded_date": "Mar 05, 2026",
    "traded_date_str": "2026 03 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sudarshan-pharma-1003813-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sudarshan Pharma Industries Ltd: Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-ltd-technical-momentum-shifts-amid-mixed-market-signals-3863607",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SudarshanPharma_technicaldot_3863607.png",
        "date": "2026-03-02 08:02:54",
        "description": "Sudarshan Pharma Industries Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite a strong day gain of 3.61% to close at ₹28.40, the stock’s technical indicators present a nuanced picture, with weekly signals showing mild bullishness while monthly trends lean bearish. This article analyses the recent price action, technical indicator signals, and broader market context to provide a comprehensive view for investors."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-3859579",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SudarshanPharma_technicaldot_3859579.png",
        "date": "2026-02-27 08:02:47",
        "description": "Sudarshan Pharma Industries Ltd has exhibited a notable shift in price momentum, moving from a mildly bearish technical stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. Despite a strong one-month return of 37.5%, the stock’s longer-term performance remains subdued, prompting a cautious outlook from analysts."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sudarshan-pharma-industries-ltd-is-rated-sell-3857863",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SudarshanPharma_mojoScore_3857863.png",
        "date": "2026-02-26 10:10:03",
        "description": "Sudarshan Pharma Industries Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 February 2026, providing investors with the most recent insights into the company’s performance and outlook."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sudarshan-pharma-industries-ltd-is-rated-sell-3840944",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SudarshanPharma_mojoScore_3840944.png",
        "date": "2026-02-15 10:10:07",
        "description": "Sudarshan Pharma Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd: Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-ltd-technical-momentum-shifts-amid-mixed-market-signals-3834360",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SudarshanPharma_technicaldot_3834360.png",
        "date": "2026-02-12 08:05:21",
        "description": "Sudarshan Pharma Industries Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a strong weekly price rally, the stock faces mixed signals from key technical indicators, reflecting uncertainty in its near-term trajectory within the Specialty Chemicals sector."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd: Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-ltd-technical-momentum-shifts-amid-mixed-market-signals-3829952",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SudarshanPharma_technicaldot_3829952.png",
        "date": "2026-02-10 08:07:26",
        "description": "Sudarshan Pharma Industries Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a strong weekly price surge of 3.43%, the stock’s longer-term performance remains subdued, prompting a detailed analysis of its technical indicators and market context."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-3827968",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SudarshanPharma_technicaldot_3827968.png",
        "date": "2026-02-09 08:03:22",
        "description": "Sudarshan Pharma Industries Ltd has witnessed a notable shift in its technical momentum, with price action surging 10.00% in a single day to close at ₹25.41. Despite this sharp uptick, the stock remains under pressure over longer time frames, reflecting a complex interplay of technical indicators and market sentiment within the Specialty Chemicals sector."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sudarshan-pharma-industries-ltd-is-rated-sell-3820419",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SudarshanPharma_mojoScore_3820419.png",
        "date": "2026-02-04 10:10:04",
        "description": "Sudarshan Pharma Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 February 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Are Sudarshan Pharma Industries Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-sudarshan-pharma-industries-ltd-latest-results-good-or-bad-3810138",
        "imagepath": "",
        "date": "2026-01-29 19:25:48",
        "description": "Sudarshan Pharma Industries Ltd's latest financial results for Q3 FY26 present a complex picture of growth tempered by margin pressures. The company reported a net profit of ₹4.36 crores, reflecting a year-on-year increase of 51.39%, while revenue reached ₹168.01 crores, marking a 45.26% rise compared to the same quarter last year. However, the operating margin, excluding other income, contracted to 6.47% from 10.14% in the previous year, indicating challenges in maintaining profitability amidst rising costs.\n\nFor the nine-month period ending December 2025, consolidated net profit was ₹12.58 crores, up 49.25% year-on-year, with revenue of ₹482.14 crores, which represents a 38.93% increase. Despite these positive growth metrics, the company's profitability margins have come under strain, with a profit after tax margin of 2.47% in Q3 FY26, down from 4.57% in the same quarter last year. This decline is attribu..."
      }
    ],
    "total": 121,
    "sid": "1003813",
    "stock_news_url": "https://www.marketsmojo.com/news/sudarshan-pharma-industries-1003813"
  },
  "announcements": [
    {
      "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Updates On GST Inspection Search And Seizure",
      "datetime": "26-Feb-2026",
      "details": "In continuation to our letter dated February 22 2026 we hereby inform you that GST inspection search and seizure operation at the registered office of the Company which commenced on February 21 2026 has concluded on February 25 2026.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - GST Inspection Search And Seizure",
      "datetime": "22-Feb-2026",
      "details": "Pursuant to Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 this is to onfirm you that GST Department Mumbai Maharashtra has initiated an inspection search and seizure operation at the registered office of the Company on February 21 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "18-Feb-2026",
      "details": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 We are delighted to inform you that the Company has obtained certificates in respect of the manufacturing facility located at Hyderabad Telangana - 501401.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sudarshan Pharma Industries Ltd has declared <strong>3%</strong> dividend, ex-date: 25 Aug 23",
          "dt": "2023-08-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sudarshan Pharma Industries Ltd has announced <strong>1:10</strong> stock split, ex-date: 22 Nov 24",
          "dt": "2024-11-22",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sudarshan Pharma Industries Ltd: Technical Momentum Shifts Amid Mixed Market Signals

2026-03-02 08:02:54

Sudarshan Pharma Industries Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite a strong day gain of 3.61% to close at ₹28.40, the stock’s technical indicators present a nuanced picture, with weekly signals showing mild bullishness while monthly trends lean bearish. This article analyses the recent price action, technical indicator signals, and broader market context to provide a comprehensive view for investors.

Read full news article

Sudarshan Pharma Industries Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

2026-02-27 08:02:47

Sudarshan Pharma Industries Ltd has exhibited a notable shift in price momentum, moving from a mildly bearish technical stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. Despite a strong one-month return of 37.5%, the stock’s longer-term performance remains subdued, prompting a cautious outlook from analysts.

Read full news article

Sudarshan Pharma Industries Ltd is Rated Sell

2026-02-26 10:10:03

Sudarshan Pharma Industries Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 February 2026, providing investors with the most recent insights into the company’s performance and outlook.

Read full news article

Sudarshan Pharma Industries Ltd is Rated Sell

2026-02-15 10:10:07

Sudarshan Pharma Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Sudarshan Pharma Industries Ltd: Technical Momentum Shifts Amid Mixed Market Signals

2026-02-12 08:05:21

Sudarshan Pharma Industries Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a strong weekly price rally, the stock faces mixed signals from key technical indicators, reflecting uncertainty in its near-term trajectory within the Specialty Chemicals sector.

Read full news article

Sudarshan Pharma Industries Ltd: Technical Momentum Shifts Amid Mixed Market Signals

2026-02-10 08:07:26

Sudarshan Pharma Industries Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a strong weekly price surge of 3.43%, the stock’s longer-term performance remains subdued, prompting a detailed analysis of its technical indicators and market context.

Read full news article

Sudarshan Pharma Industries Ltd Sees Mixed Technical Signals Amid Price Momentum Shift

2026-02-09 08:03:22

Sudarshan Pharma Industries Ltd has witnessed a notable shift in its technical momentum, with price action surging 10.00% in a single day to close at ₹25.41. Despite this sharp uptick, the stock remains under pressure over longer time frames, reflecting a complex interplay of technical indicators and market sentiment within the Specialty Chemicals sector.

Read full news article

Sudarshan Pharma Industries Ltd is Rated Sell

2026-02-04 10:10:04

Sudarshan Pharma Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 February 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Are Sudarshan Pharma Industries Ltd latest results good or bad?

2026-01-29 19:25:48

Sudarshan Pharma Industries Ltd's latest financial results for Q3 FY26 present a complex picture of growth tempered by margin pressures. The company reported a net profit of ₹4.36 crores, reflecting a year-on-year increase of 51.39%, while revenue reached ₹168.01 crores, marking a 45.26% rise compared to the same quarter last year. However, the operating margin, excluding other income, contracted to 6.47% from 10.14% in the previous year, indicating challenges in maintaining profitability amidst rising costs. For the nine-month period ending December 2025, consolidated net profit was ₹12.58 crores, up 49.25% year-on-year, with revenue of ₹482.14 crores, which represents a 38.93% increase. Despite these positive growth metrics, the company's profitability margins have come under strain, with a profit after tax margin of 2.47% in Q3 FY26, down from 4.57% in the same quarter last year. This decline is attribu...

Read full news article

View All News